Skip to main content Navigation

Articles and News

Alexis Jae Jewelry Donates 25% Of Its Profits to Breast Cancer Research May 27, 2022 (0 comments)

Alexis Jae

New York, NY--Alexis Jae Jewelry is transforming the fine jewelry industry by removing costly mark-ups while giving back to a cause the brand's founder is passionate about. Twenty-five percent of Alexis Jae Jewelry's profits are directly donated to support breast cancer research. 

"Breast cancer has impacted too many of my close friends and family," says Alexis Taub, founder of Alexis Jae Jewelry, in a press release. "We are committed to being part of finding a cure for this terrible disease. That is why we donate 25% of our profits to A Cure In Our Lifetime, an organization dedicated to funding the top breast cancer researchers globally," 

The inspiration for Alexis Jae Jewelry, notes the press release, comes from its founder, Alexis Taub, an entrepreneur whose family has been manufacturing fine jewelry for generations. Before founding Alexis Jae Jewelry, Taub found immense joy in helping others design their custom jewelry pieces while saving money. As the manufacturer, Alexis Jae Jewelry delivers custom pieces directly to the consumer. 

Beyond their curated collection, Alexis Jae Jewelry offers a unique custom option. The first step in the process is a design consultation where the customer communicates their vision. Alexis Jae Jewelry provides expert guidance and helps each customer perfect their idea. Finally, the customer is provided with a computer-generated design for approval. Once the digital design is approved, customers receive a one-of-a-kind piece within six to eight weeks. 

In addition to offering consumers wholesale prices, this woman-owned brand has dedicated itself to furthering cancer research and treatment advancements. When customers choose Alexis Jae Jewelry, it's guaranteed that twenty-five percent of all profits will be donated to life-saving breast cancer research. 

Read more in the entire news release.

Share This:

Leave a Comment:

Human Check